On November 10, ILUVATAR COREX rose 10.3% in Regular Trading, trading at HK$67.65, with turnover of HK$116 million.
The move coincided with continued market focus on the company’s recently disclosed TianGai 300 validation data, which showed that under a typical PD-separated deployment, normalized single-card end-to-end throughput reached 1.05 times that of a leading international mainstream GPU, while the IXL144 supernode reduced cost per million effective tokens by about 40% versus mainstream international alternatives.
Additional disclosed operating indicators also supported attention on commercialization progress. The company said chip shipments in the first ten months exceeded 80,000 units, and its latest reported first-half revenue was RMB946 million, up 191.6% year over year. Taken together, third-party performance verification, token-cost economics, and shipment growth form the main publicly available backdrop for the stock’s current strength.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments